SCHEMBL63026

SCHEMBL63026

F[B-](F)(F)F.F[B-](F)(F)F.F[B-](F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL343401 1.00
SCHEMBL16047646 1.00
SCHEMBL63222 1.00
SCHEMBL7107352 1.00
SCHEMBL6216 1.00
SCHEMBL5132904 1.00
Hydrochloric Acid SCHEMBL23290033 0.89
Iodide SCHEMBL25170857 0.89
SCHEMBL20942947 0.89
SCHEMBL23581769 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3297 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12616761-B2 CXCR4-targeting compounds THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2026-05-05 US claimed
EP-4695322-A2 CONJUGATE ACID PROTON EXCHANGE POLYMERS AND METHODS OF MAKING AND USING CONJUGATE ACID PROTON EXCHANGE POLYMERS 1S1 Energy, Inc. (US) 2026-02-18 EP claimed
US-12551578-B2 Compound or salt thereof SHIZUOKA PREFECTURAL UNIVERSITY CORPORATION (JP) 2026-02-17 US claimed
US-12522585-B2 Method for preparing 2-chloro-n-(1-cyanocyclopropyl)-5-[2′-methyl-5′-(pentafluoroethyl)-4′-(trifluoromethyl)-2′h-1,3′-bipyrazol-4-yl]benzamide VETOQUINOL SA (FR) 2026-01-13 US claimed
US-12472272-B2 Radiolabelled compounds for diagnosis or treatment of prostate-specific membrane antigen- expressing cancer PROVINCIAL HEALTH SERVICES AUTHORITY (CA) 2025-11-18 US claimed
US-20250340519-A1 RADIOLABELLED COMPOUND OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2025-11-06 US claimed
EP-4624459-A2 RADIOLABELLED COMPOUND Oxford University Innovation Limited (GB) 2025-10-01 EP claimed
US-12427209-B2 Dual mode 18F-labelled theranostic compounds and uses thereof PROVINCIAL HEALTH SERVICES AUTHORITY (CA) 2025-09-30 US claimed
US-20250242064-A1 CXCR4-TARGETING COMPOUNDS, AND METHODS OF MAKING AND USING THE SAME ALPHA-9 ONCOLOGY INC. (CA) 2025-07-31 US claimed
WO-2025147774-A1 COMPOSITIONS TARGETING BRADYKININ RECEPTOR B1 FOR MEDICAL IMAGING AND TREATMENT OF CANCER AND OTHER DISORDERS ALPHA-9 ONCOLOGY INC. (CA) 2025-07-17 WO claimed
EP-0930311-B1 PROCESS FOR PREPARING 1,3-DIOXOLANE-4-METHANOL COMPOUNDS DAISO CO LTD (JP) 2003-11-26 EP claimed
EP-0926147-B1 PROCESS FOR PREPARING 1,3-DIOXOLANE-4-METHANOL COMPOUNDS DAISO CO LTD (JP) 2003-08-27 EP claimed
US-6569651-B1 Incubating the monomers with a dodecylbenzenesulfonic acid micelle as template and an enzyme so that the monomer aligns along the template and polymerizes to form a polymer-template complex; electrical and optical stability, conductivity THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2003-05-27 US claimed
US-6465541-B2 CONSISTS OF A CATIONICALLY POLYMERIZABLE ACTIVE FUNCTIONAL GROUP; A POLYMERIZATION CTALYST CAPABLE OF INITIATING CATIONIC POLYMERIZATION AND A FILLER CONTAINING METAL OXIDES, HALIDES, BORATES, PHOSPHATES, SILICATES CARBONATES ETC. 3M INNOVATIVE PROPERTIES COMPANY 2002-10-15 US claimed
US-20020045718-A1 Sulphured-metallic coordinated complexes in polyadditive catalysis RIO OESTE, S.A. (GT) 2002-04-18 US claimed
US-6143908-A Process for preparation of 1,3-dioxolane-4-methanol compounds DAISO CO., LTD. (JP) 2000-11-07 US claimed
US-6124479-A Process for the preparation of 1,3-dioxolane-4-methanols DAISO CO., LTD. (JP) 2000-09-26 US claimed
EP-0930311-A1 PROCESS FOR PREPARING 1,3-DIOXOLANE-4-METHANOL COMPOUNDS DAISO CO., LTD. (JP) 1999-07-21 EP claimed
EP-0926147-A1 PROCESS FOR PREPARING 1,3-DIOXOLANE-4-METHANOL COMPOUNDS DAISO CO., LTD. (JP) 1999-06-30 EP claimed
EP-0601942-B1 Membranes for ion transport and method for obtaining them KODAK PATHE (FR) 1997-03-26 EP claimed